Niagen Bioscience (NAGE) Short term Debt (2016 - 2018)
Niagen Bioscience (NAGE) posted quarterly Short term Debt of $137000.0 for Q4 2018, down 55.81% year-over-year from $310000.0 in Q4 2017, and down 55.81% quarter-over-quarter from $310000.0 in Q4 2017.
Niagen Bioscience (NAGE) Short term Debt (2016 - 2018) Analysis & Trends
Niagen Bioscience (NAGE) has reported Short term Debt for 3 consecutive years, with $137000.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Short term Debt fell 55.81% year-over-year to $137000.0; the TTM figure through Dec 2018 stood at $137000.0 (down 55.81% YoY), while the FY2018 annual figure was $137000.0, down 55.81% from the prior year.
- Short term Debt eased to $137000.0 in Q4 2018 per NAGE's latest filing, from $310000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $1.5 million in Q1 2016 and bottomed at $137000.0 in Q4 2018.
- Historically, Short term Debt has averaged $579894.5 across 3 years, with a median of $327000.0 in 2016.
- Annual changes were most pronounced in 2016 — Short term Debt slumped 77.5% — and 2017, when it decreased 9.88%.
- Niagen Bioscience's Short term Debt stood at $344000.0 in 2016, then retreated by 9.88% to $310000.0 in 2017, then tumbled by 55.81% to $137000.0 in 2018.
- Business Quant data shows NAGE's Short term Debt at $137000.0 in Q4 2018, $310000.0 in Q4 2017, and $344000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Niagen Bioscience | 238.30 Mn | 171.56 Mn | 19.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 137,000.00 |
| Dec 30, 2017 | 310,000.00 |
| Dec 31, 2016 | 344,000.00 |
| Jan 2, 2016 | 1.53 Mn |